or Try an Advanced Search...

    Technical Analysis for BGXX - Bright Green Corporation

    Grade Last Price % Change Price Change
    F 0.18 -6.12% -0.01
    BGXX closed down 6.12 percent on Thursday, April 25, 2024, on 38 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Down
    Historical BGXX trend table...
    Date Alert Name Type % Chg
    Expansion Breakdown Bearish Swing Setup 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Wide Bands Range Expansion 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Down 4 Days in a Row Weakness 0.00%
    Down 5 Days in a Row Weakness 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    Lower Bollinger Band Walk Weakness -6.12%
    Outside Day Range Expansion -6.12%
    Older End-of-Day Signals for BGXX ...

       Recent Intraday Alerts

    Alert Time
    Up 1% about 11 hours ago
    60 Minute Opening Range Breakdown about 14 hours ago
    Fell Below Lower Bollinger Band about 14 hours ago
    Down 10% about 14 hours ago
    Down 1 ATR about 14 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    BGXX Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Bright Green is one of the very few companies selected by the US government to grow, manufacture, and sell, legally under federal and state laws, cannabis and cannabis-related products for research, pharmaceutical applications and affiliated export. Our conditional approval based on already agreed terms from the U.S. Drug Enforcement Administration gives us the opportunity to advance our vision of improving quality of life through the opportunities presented by cannabis-derived therapies.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Medicine Health Sciences Cannabis Euphoriants Entheogens Medicinal Plants Us Government Herbalism Medical Cannabis Drug Control Law

    Is BGXX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 14 Bright Green to install 102-megawatt solar power generation field
    Mar 14 BRIGHT GREEN ANNOUNCES ITS EXPANSION CONTINUATION WITH A $100 MILLION SOLAR POWERED GENERATION FIELD TO SUPPLY HEAT AND ELECTRICITY TO ITS DRUG PRODUCTION AND MANUFACTURING FACILITY.
    Mar 12 BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING
    Mar 7 Bright Green Corporation (BGXX) submits for historic DEA Registration for Production of Schedule I and Schedule II controlled substances.
    Feb 22 BRIGHT GREEN CORPORATION GAINS MOMENTUM FOR THEIR “DRUGS MADE IN AMERICA” PLATFORM WITH APPROVAL FOR THE RESEARCH, PRODUCTION AND MANUFACTURING OF ALL SCHEDULE I AND SCHEDULE II PLANT-BASED DRUGS
    Feb 17 BRIGHT GREEN CORPORATION ANNOUNCES CHANGES TO BOARD OF DIRECTORS
    Jan 25 Bright Green Corporation announces the agreement to acquire platform technologies and associated intellectual property from C2 Wellness Corp.
    Jan 14 (Updated) U.S. Legal Cannabis Pioneer Bright Green Corporation Appoints Industry Veteran Groovy Singh as New Chief Executive Officer
    Dec 27 12 Most Profitable Pot Stocks Now
    Nov 22 DEA-Registered Marijuana Producer's Q3 2023 Financial Report: Reduced Expenses, Strategic Focus, Aligned Net Loss
    See more BGXX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.8036
    52 Week Low 0.15
    Average Volume 2,404,523
    200-Day Moving Average 0.37
    50-Day Moving Average 0.24
    20-Day Moving Average 0.23
    10-Day Moving Average 0.21
    Average True Range 0.03
    RSI (14) 31.03
    ADX 31.26
    +DI 16.66
    -DI 26.06
    Chandelier Exit (Long, 3 ATRs) 0.20
    Chandelier Exit (Short, 3 ATRs) 0.24
    Upper Bollinger Bands 0.28
    Lower Bollinger Band 0.18
    Percent B (%b) 0.01
    BandWidth 43.73
    MACD Line -0.02
    MACD Signal Line -0.01
    MACD Histogram -0.0064
    Fundamentals Value
    Market Cap 33.83 Million
    Num Shares 184 Million
    EPS -0.05
    Price-to-Earnings (P/E) Ratio -3.68
    Price-to-Sales 0.00
    Price-to-Book 2.00
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.24
    Resistance 3 (R3) 0.24 0.22 0.23
    Resistance 2 (R2) 0.22 0.20 0.22 0.23
    Resistance 1 (R1) 0.20 0.20 0.19 0.20 0.23
    Pivot Point 0.18 0.18 0.17 0.18 0.18
    Support 1 (S1) 0.16 0.17 0.15 0.16 0.14
    Support 2 (S2) 0.14 0.16 0.14 0.14
    Support 3 (S3) 0.12 0.14 0.13
    Support 4 (S4) 0.12